Primemd (PRMD) Stock Price

Primemd Price

Delisted·Aug 27, 2026
0.00
+0.00 (+0.00 %)
Last traded price

Revenue has compounded at 3.2% per year over the past 5 years to 67,800.00 USD. Primemd's net margin stands at -149.1%, up from -256.9% several years earlier. The stock trades about 389% above its 52-week low.

Primemd stock price

Access this data via the Eulerpool API

Primemd business model & stock analysis

Frequently asked questions about Primemd

Converted at the current exchange rate, the Primemd share trades at 0.00 EUR (0.00 USD).

No history available for Primemd.

The revenue cannot currently be calculated for Primemd.

The profit cannot currently be calculated for Primemd.

The P/E ratio cannot be calculated for Primemd at the moment.

The P/S cannot be calculated for Primemd currently.

The Eulerpool Quality Score for Primemd is 3/10.

The ISIN of Primemd is US74167A1016. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Primemd is PRMD. The ticker symbol is used to trade Primemd shares on the stock exchange.

Primemd paid dividends every year for the past 0 years.

Primemd is assigned to the '—' sector.

The dividends of Primemd are distributed in USD.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
—
Industry
Other
Number of shares
Employees
Revenue per Employee
67,800.00 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website primemd.com
Currency
USD
Initial public offering
Oct 27, 1993
ISIN
US74167A1016
Cusip
74167A101
Market capitalization
10,000.00 USDMicro Cap
52-Week Range
0.00–0.00USD
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.23 %
Gross Margin
—
EBIT Margin
-158.41 %
Net Margin
-149.12 %
EPS (Earnings Per Share)
-0.03 USD
Net Debt / EBIT
3.87
Debt/Equity
0.00
Last updated Sep 27, 2026, 10:19 AM

Primemd Peer Group

Primemd Ticker

OTC · PRMD

Primemd FIGI

PRMD:US · BBG000BD7DR3PRMD:PQ · BBG000BD7LT3PRMD:UV · BBG000BD7N00

All fundamentals and in-depth analysis of Primemd

Our stock analysis for Primemd stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Primemd. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.